Additional information
Colourless,Semi Powder
78919-26-3
ACI-033404
NA
C24H21O4
490.4
Ambient
2-8°C
Antiplatelet agent
Pharmaceutical Impurity Standards
Methyl (2R)-(2-chlorophenyl)[(2S)-(2-chlorophenyl)[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetyloxy]acetate
Methyl (2R)-(2-chlorophenyl)[(2S)-(2-chlorophenyl)[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetyloxy]acetate
(4R)-4-[(3S,5S,7S,8S,9S,10R,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid





![sec-BUTYL PACLITAXEL (25 mg) ((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (αR,βS)-α-hydroxy-β-[[(2S)-2-methyl-1-oxobutyl]amino]benzenepropanoate)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)